The global protein extracts from single cell protein and other conventional sources market size was valued at USD 20.4 billion in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 7.3% from 2023 to 2030. Key drivers attributed to the market expansion include growing demand for food and feed with low-fat concentration and optimal amino acid composition. Furthermore, demand for products that can be manufactured using ethically sustainable production is anticipated to drive progress in this sector over the forecast period. Although soy-derived products enjoy the success of proactively positioning as a sustainable source of protein, a higher preference for the functional role than the nutritional role is projected to drive R&D.
The growing demand for protein-rich food and beverages is fueling the market's growth. According to a report by Gym Desk, 185 million people worldwide have a gym membership and require a high-protein diet to build muscles or lose weight. Applications for proteins in biomedicine include tissue engineering, medication delivery, and diagnostics. For instance, proteins can produce new tissues or organs or deliver medications to certain cells or tissues. These are various drivers fueling the growth of the market.
Technological advancements in producing proteins derived from a single cell are expected to drive the industry with lucrative growth. Development in products for personalized nutrition is anticipated to add to growth in this sector as R&D in nutraceuticals is expected to aid the acceptance of such products. Several research papers are being published using protein obtained from the single-cell protein and another microbial origin.
Genetically modified yeast obtained from bioethanol factories is already employed as feed for cattle in several countries. Owing to single-cell protein (SCP) advantages, these products are preferred in animal feed and for human consumption. Companies such as DuPont are engaged in yeast genetic engineering to produce long-chain omega-3 fatty acids essential to human health. A substantial number of players producing Spirulina and Chlorella are major sources of revenue generation in this market.
For instance, BlueBiotech Int GmbH is a micro-algal biotechnology company that has operated for over 20 years, producing large quantities of Spirulina and Chlorella. Similarly, Cyanotech Corporation produces spirulina with sales in the U.S. and 30 other countries. Moreover, spirulina has obtained Generally Recognized as Safe (GRAS) status from the U.S. FDA for its usage as a food ingredient.
Also, the companies are engaged in providing spirulina in the form of a nutritional drink. The drink contains the live form of spirulina to serve as a probiotic rather than just a nutritional supplement. Companies are masking spirulina's taste to gain a competitive edge.
The application of spirulina as a multipurpose nutraceutical drives the research interest of manufacturers in a single cell-derived product, thus boosting growth in this sector. The applications include antioxidants, B vitamin sources, chlorophyll enhancers, and alkaliser. Spirulina production is considered a low-income high investment program as it promises the farmers a better income than regular crops with low investment.
The source market is segmented into plant protein extract sources, microbial sources - single cell proteins, and microbial sources -direct use. The plant protein extract source segment accounted for the largest revenue share in 2022. The presence of a large number of methods for the extraction of plant proteins is anticipated to result in the dominance of this segment in the coming years. Quinoa is an example of a plant protein containing all nine necessary amino acids that humans require. According to research from Colorado State University, substituting plant-based protein sources for certain animal-based proteins may help lower the chance of acquiring chronic illnesses, including heart disease, diabetes, and some malignancies. Important antioxidants, vitamins, and minerals included in plant-based diets benefit general health.
The microbial sources - single-cell protein segment is expected to grow at the fastest CAGR over the forecast period. Bacteria have been majorly used as SCPs over the past years, and this usage rate is anticipated to grow during the forecast period. Bacterial SCP generally contains 50-80% protein on a dry weight basis. Methionine content in bacterial SCP is observed to be more than algal or fungal proteins. Food-grade substrates are usually employed for the production of SCP for human consumption. However, other processes are under the development phase for SCP production from inexpensive waste materials.
The waste materials include forestry, agricultural sources, and food & beverage processing industries. Moreover, the availability of a substantial number of SCPs in the market used as a high protein source for animal feed has resulted in a significant share of this segment. Furthermore, developments continue to take place, and these developments are expected to maintain the growth of SCP extract throughout the forecast period.
Bacteria have been majorly used as SCPs over the past years, and this usage rate is anticipated to grow during the forecast period. Bacterial SCP generally contains 50-80% protein on a dry weight basis. Methionine content in bacterial SCP is observed to be more than algal or fungal proteins. This segment continues to witness development concerning production capabilities, which is expected to enhance the production of bacteria-based SCPs.
Based on application, the market is segmented into biotechnology, animal feed, agriculture & fertilizers, and others. The biotechnology segment held the largest revenue of 56.6% market share in 2022. Biotechnology has various uses in protein extraction; it is used in protein purification, identification, and characterization. Some specific examples of biotechnology in protein extraction are recombinant DNA technology to produce protein in bacteria or yeast use of liquid chromatography-mass spectrometry to identify proteins.
Protein plays a pivotal role in various fields of biotechnology, including pharmacy, cell cultivation, nutraceuticals, and cosmetics. Companies involved in the manufacture of nutraceuticals and cosmetics are observed to be the major beneficiaries. This can be attributed to the availability of many sources employed within the nutraceuticals and cosmetics industry.
The animal feed segment is expected to grow at the fastest CAGR of 7.4% over the forecast period. Domestic animals continue to make substantial contributions to the global food supply, which has led to animal feeds becoming an increasingly important component of the integrated food chain. Approximately 30% of the worldwide value of agriculture and 19% of the value of food production are accounted for by animal products, which also provide 34% of the protein and 16% of the calories in human diets. A steady stream of acceptable, reasonably priced, and secure animal feeds is crucial to satisfying customer demand for more meat, milk, eggs, and other livestock products.
North America dominated the market and accounted for a revenue share of 36.5% in 2022. The introduction of mature biotechnology techniques, coupled with major firms operating in this region, is driving regional growth. U.S.-based companies like Cyanotech Corporation, Nucelis, and KnipBio have contributed to the major share in the global SCPs market. These companies are recognized as prominent producers of SCP and have contributed to major revenue generation by selling their products, such as Spirulina.
The Middle East and Africa region is expected to grow at the fastest CAGR of 8.4% during the forecast period as countries are undertaking efforts to enhance their share in the global animal feed industry. Asia Pacific is expected to emerge as a lucratively growing region. Furthermore, although China sustained its position as the top feed-producing country with 187.20 million metric tons, India, Japan, Pakistan, and Vietnam have also been observed to have made significant contributions to the Asian region.
The market is characterized by many manufacturers engaging in strategies such as new product launches, approvals, mergers & acquisitions, and collaborations to maintain and grow their global reach. For instance, in May 2021, Unilever announced a partnership with ENOUGH, a food-tech company, aiming at producing and bringing new plant-based meat products to market. In February 2018, American feed ingredient pioneer KnipBio introduced a new range of KnipBio Meal products containing bio-astaxanthin. This carotenoid gives salmon, trout, and prawns their distinctive pink color and its health advantages. The following are some of the major participants in the global protein extracts from single cell protein and other conventional sources market:
Unilever
Taiwan Chlorella Manufacturing Company
CBH
Xiamen Hyfine Gelatin Co. ltd
BlueBio Tech GmbH
Euglena Co. ltd
Corbion Biotech, Inc
KnipBio
Hangzhou
Earthrise Nutritional
Report Attribute |
Details |
Market size value in 2023 |
USD 22.2 billion |
Revenue forecast in 2030 |
USD 36.4 billion |
Growth rate |
CAGR of 7.3% from 2023 to 2030 |
Base year for estimation |
2022 |
Historical data |
2018 - 2021 |
Forecast period |
2023 - 2030 |
Report updated |
September 2023 |
Quantitative units |
Revenue in USD million/billion, and CAGR from 2023 to 2030 |
Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
Segments covered |
Type, application, region |
Regional scope |
North America; Europe; Asia Pacific; Latin America; MEA |
Country scope |
U.S.; Canada; UK; Germany; France, Italy; Spain; Denmark; Sweden; Norway; Japan; China; India; South Korea; Australia; Thailand; Mexico; Brazil; Argentina; South Africa; Saudi Arabia; UAE; Kuwait |
Key companies profiled |
Unilever; Taiwan Chlorella Manufacturing Company; CBH; Xiamen Hyfine Gelatin Co. ltd; BlueBio Tech GmbH; Euglena Co. ltd; Corbion Biotech, Inc; KnipBio; Hangzhou; Earthrise Nutritional |
Customization scope |
Free report customization (equivalent up to 8 analyst’s working days) with purchase. Addition or alteration to country, regional & segment scope |
Pricing and purchase options |
Avail customized purchase options to meet your exact research needs. Explore purchase options |
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For the purpose of this study, Grand View Research has segmented the global protein extracts from single cell protein and other conventional sources market report on the basis of source, application, and region:
Source Outlook (Revenue, USD Million, 2018 - 2030)
Plant Protein Extract Sources
Microbial Sources - Single Cell Proteins
Microbial Sources - Direct Use
Application Outlook (Revenue, USD Million, 2018 - 2030)
Biotechnology
Pharma
Cell Culture Media
Others
Animal Feed
Animal Feed by Sources
Plant Protein Extract Sources
Microbial Sources - Single Cell Proteins
Bacteria
Yeast
Algae
Fungi
Microbial Sources - Direct Use
Animal Feed by Grades
Concentrates
Isolates
Hydrolysates
Animal Feed by Animal Type
Livestock
Poultry
Pig
Cattle
Other Livestock
Fish Feed
Companion/Pet Animals
Agriculture & Fertilizers
Others
Regional Outlook (Revenue, USD Million, 2018 - 2030)
North America
U.S.
Canada
Europe
UK
Germany
France
Italy
Spain
Denmark
Sweden
Norway
Asia Pacific
Japan
China
India
Australia
Thailand
South Korea
Latin America
Brazil
Mexico
Argentina
Middle East and Africa
South Africa
Saudi Arabia
UAE
Kuwait
b. The global protein extracts from single cell protein and other conventional sources market size was estimated at USD 20.4 billion in 2022 and is expected to reach USD 22.20 billion in 2023.
b. The global protein extracts from single cell protein and other conventional sources market is expected to grow at a compound annual growth rate of 7.3% from 2023 to 2030 to reach USD 36.40 billion by 2030.
b. Biotechnology-related applications dominated the protein extracts from single cell protein and other conventional sources with a share of 56.59% in 2022. This is attributable to the growing popularity of biotech products and increasing investment in this sector.
b. Some key players operating in the protein extracts from single cell protein and other conventional sources market include KnipBio; BlueBioTech Int. GmbH; Lallemand Inc; Marlow Foods Limited are some key players operating in this market. Tangshan Top Bio-technology Co., Ltd; XIAMEN HYFINE GELATIN CO., LTD.
b. Key factors that are driving the market growth include commercial success of single-cell protein such as spirulina and chlorella as an alternative protein source coupled with technological advancements in single cell production. Furthermore, technological advancements in the production of the proteins derived from a single cell are expected to drive the industry with lucrative growth.
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities. Contact us now
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.
"The quality of research they have done for us has been excellent."